Clinical Trial Update: Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) [Phase 2]

View source ↗

Summary

Phase 2 trial of aldafermin (NGM282) for chronic diarrhea due to bile acid malabsorption has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Acid Malabsorption
• Diarrhea
• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Aldafermin (aldafermin)

Snippet

Sponsor: Michael Camilleri, MD | Conditions: Chronic Diarrhea, Irritable Bowel Syndrome With Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2023-10-12